BioCentury | Jan 28, 2020
Company News

Quenching the flames of inflammatory cell death

...Inhibition of gasdermin to prevent inflammatory cell death Origin of technology: Max Planck Institute and Lead Discovery Center GmbH...
BioCentury | Feb 5, 2019
Distillery Therapeutics

Neurology

...antagonist, in Phase II testing for inflammation and Phase I testing for rheumatoid arthritis (RA). Lead Discovery Center GmbH...
BioCentury | Aug 16, 2018
Distillery Therapeutics

Neurology

...antagonist EVT401 in Phase II testing for inflammation and Phase I testing for rheumatoid arthritis. Lead Discovery Center GmbH...
BioCentury | Jul 19, 2018
Translation in Brief

Public Funding Highlights: 2Q18

...expertise and infrastructure in Germany's North Rhine-Westphalia state. The partners -- Biomedical Center Dortmund , Lead Discovery Center...
BioCentury | May 17, 2018
Finance

Europe’s piece of the pie

...like J&J’s JLABS in Belgium, and organizations such as the U.K.’s Francis Crick Institute, Germany’s Lead Discovery Center GmbH...
...& Johnson (NYSE:JNJ), New Brunswick, N.J. Junction Therapeutics Ltd., Dublin, Ireland Karolinska Institute, Stockholm, Sweden Lead Discovery Center GmbH...
...“Found in translation.” BioCentury Innovations (2016) Lauren Martz, Senior Writer Francis Crick Institute Johnson & Johnson Development Corp. Karolinska Institute Lead Discovery Center GmbH Sofinnova...
BioCentury | Jan 23, 2018
Distillery Therapeutics

Transplant

...in Phase II testing to treat inflammation and Phase I testing to treat rheumatoid arthritis. Lead Discovery Center GmbH...
BioCentury | Nov 9, 2017
Finance

The return of big

...preclinical cancer pipeline with its third PPP since October 2016: a discovery research collaboration with Lead Discovery Center GmbH...
...undisclosed targets that form the basis for the collaboration. Researchers from Max Planck and the Lead Discovery Center...
...Institute (IBRI), Indianapolis, Ind. Indiana University, Indianapolis, Ind. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Lead Discovery Center GmbH...
BioCentury | Jul 21, 2017
Company News

Max Planck Society, Lead Discovery Center and Daiichi partner to discover cancer compounds

...Max Planck Society (Munich, Germany) and Lead Discovery Center GmbH (Dortmund, Germany) and Daiichi Sankyo Co. Ltd. (Tokyo:4568) partnered...
...proliferation. Max Planck and Daiichi will fund the discovery portion of the deal at the Lead Discovery Center...
...development and sales milestones as well as royalties. The partners declined to disclose additional details. Lead Discovery Center GmbH...
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...Enthera s.r.l. last November from research at San Raffaele Hospital . In addition, the longer-standing Lead Discovery Center GmbH...
...Cancer Preclinical £13.2 ($17) GammaDelta Therapeutics Ltd. (London, U.K.) γδT cell therapies Cancer Preclinical ND Lead Discovery Center GmbH...
...Ltd., Dublin, Ireland Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Kymab Group Ltd., Cambridge, U.K. Lead Discovery Center GmbH...
BioCentury | May 24, 2017
Distillery Therapeutics

Endocrine / Metabolic

...P2RX7 antagonist, in Phase II testing for inflammation and Phase I testing for rheumatoid arthritis. Lead Discovery Center GmbH...
Items per page:
1 - 10 of 54
BioCentury | Jan 28, 2020
Company News

Quenching the flames of inflammatory cell death

...Inhibition of gasdermin to prevent inflammatory cell death Origin of technology: Max Planck Institute and Lead Discovery Center GmbH...
BioCentury | Feb 5, 2019
Distillery Therapeutics

Neurology

...antagonist, in Phase II testing for inflammation and Phase I testing for rheumatoid arthritis (RA). Lead Discovery Center GmbH...
BioCentury | Aug 16, 2018
Distillery Therapeutics

Neurology

...antagonist EVT401 in Phase II testing for inflammation and Phase I testing for rheumatoid arthritis. Lead Discovery Center GmbH...
BioCentury | Jul 19, 2018
Translation in Brief

Public Funding Highlights: 2Q18

...expertise and infrastructure in Germany's North Rhine-Westphalia state. The partners -- Biomedical Center Dortmund , Lead Discovery Center...
BioCentury | May 17, 2018
Finance

Europe’s piece of the pie

...like J&J’s JLABS in Belgium, and organizations such as the U.K.’s Francis Crick Institute, Germany’s Lead Discovery Center GmbH...
...& Johnson (NYSE:JNJ), New Brunswick, N.J. Junction Therapeutics Ltd., Dublin, Ireland Karolinska Institute, Stockholm, Sweden Lead Discovery Center GmbH...
...“Found in translation.” BioCentury Innovations (2016) Lauren Martz, Senior Writer Francis Crick Institute Johnson & Johnson Development Corp. Karolinska Institute Lead Discovery Center GmbH Sofinnova...
BioCentury | Jan 23, 2018
Distillery Therapeutics

Transplant

...in Phase II testing to treat inflammation and Phase I testing to treat rheumatoid arthritis. Lead Discovery Center GmbH...
BioCentury | Nov 9, 2017
Finance

The return of big

...preclinical cancer pipeline with its third PPP since October 2016: a discovery research collaboration with Lead Discovery Center GmbH...
...undisclosed targets that form the basis for the collaboration. Researchers from Max Planck and the Lead Discovery Center...
...Institute (IBRI), Indianapolis, Ind. Indiana University, Indianapolis, Ind. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Lead Discovery Center GmbH...
BioCentury | Jul 21, 2017
Company News

Max Planck Society, Lead Discovery Center and Daiichi partner to discover cancer compounds

...Max Planck Society (Munich, Germany) and Lead Discovery Center GmbH (Dortmund, Germany) and Daiichi Sankyo Co. Ltd. (Tokyo:4568) partnered...
...proliferation. Max Planck and Daiichi will fund the discovery portion of the deal at the Lead Discovery Center...
...development and sales milestones as well as royalties. The partners declined to disclose additional details. Lead Discovery Center GmbH...
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...Enthera s.r.l. last November from research at San Raffaele Hospital . In addition, the longer-standing Lead Discovery Center GmbH...
...Cancer Preclinical £13.2 ($17) GammaDelta Therapeutics Ltd. (London, U.K.) γδT cell therapies Cancer Preclinical ND Lead Discovery Center GmbH...
...Ltd., Dublin, Ireland Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Kymab Group Ltd., Cambridge, U.K. Lead Discovery Center GmbH...
BioCentury | May 24, 2017
Distillery Therapeutics

Endocrine / Metabolic

...P2RX7 antagonist, in Phase II testing for inflammation and Phase I testing for rheumatoid arthritis. Lead Discovery Center GmbH...
Items per page:
1 - 10 of 54